Participation eligibility
Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.
Inclusion Criteria:
Age 0-90 years
Documentation of confirmed diagnosis of PCD. For the pilot, diagnosis by either hallmark ciliary ultrastructure abnormality confirmed at a PCD expert site OR two known disease-causing mutations in a known PCD gene. For subsequent enrollment individuals diagnosed by low nNO testing (<77nl/min) on two separate occasions at least two months apart plus a compatible clinical phenotype will also be included
Written informed consent, and assent for minors as applicable
Followed as a patient at a PCD Foundation Clinical and Research Network center in North America
Exclusion Criteria:
Note: Other protocol defined Inclusion/Exclusion Criteria may apply.
Eligibility last updated 11/05/2025. Questions regarding updates should be directed to the study team contact.